Article
Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates
23 Jun 2018
Abstract excerpt
BACKGROUND: Alzheimer's disease (AD) is a multifactorial and complex neuropathology that involves impairment of many intricate molecular mechanisms. Despite recent advances, AD pathophysiological characterization remains incomplete, which hampers the development of effective treatments. In fact, currently, there are no effective pharmacological treatments for AD. Integrative strategies such as transcription...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
